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ABSTRACT: A sulphydryl plant protease present in the latex of Ficus hispida Linn affects 
hatematological values in mice.  The isolated protease was found to increase clotting time and 
erythrocyte sedimentation rate while haemoglobin conten, RBC count and WBC count were 
decreased in a dose dependent manner.  Ointment containing 1.0% (w/w) hispidain in washable 
ointment base showed good wound healing property in mice. The protease also possesses mild 
anti inflammatory activity. 
 
Ficus hispida Linn (Family: Moraceae), is a 
moderate sized tree available in India and 
some other tropical countries
1-5.  Apart from 
other uses, different parts of the plant are 
used in the treatment of hacmorrhage of 
nose and mouth, some diseases of blood, 
and treatment of boils and wounds in the 
traditional system of medicine
2,3.  The plant 
on injury exudes a milky and sticky latex
4.  
The isolation of a protease form the latex, its 
purification and some of its physico-
chemical properties have been reported
6.  
The temperature and PH for optimum 
activity was 40ocand 7.0 respectively using 
casein as substrate. Later, we purified the 
protease further by sephadex G-200 gel 
filtration upto 36 folds with a yield of 5.22% 
and determinined the molecular weight of 
the protease by sephadex G-100 gel 
filtration which was found to be around 
23,700 daltons (unpublished work). Acute 
toxicity of the sample of protease has been 
studied (LD50=1230 mg/kg body weight in 
mice, intraperitoneal). 
 
The present work deals with the study of the 
effects of the protease on haematological 
values in mice, on healing of wounds, and 
its effect on in flammatory conditions. 
 
EXPERIMENTAL 
 
Materials: 
 
The protease isolated from the crude extract 
of the latex of Ficus hispida Linn by 
precipitation with 40-60% ammonium 
sulphate followed by dialysis and 
iyophilization
6  was used for the study.   
Albino mice of either sex weighing between 
18-24 and albino rats pf either sex weighing 
between 150-200g where purchased from 
M/S B.N Ghosh, Calcutta. Heparin Sodium 
injection (5000 i.u. per ml, Beparine, 
Biological E.), Soframycin skin cream 
containing 1.0% (W/W) Framycetin 
Sulphate in; washable base (Hoechst Marion 
Roussel itd., Mumbai) and Vovaran 
injection (Dominion pharmaceuticals pvt. 
Ltd., Bangalore) were purchased from 
market. Water washable ointment base7 was 
prepared in our laboratory.  All other 
chemicals were purchased form either E. 
Merck India Ltd., or Ranbaxy laboratories 
Ltd and were of analytical grade. 
 
Methods: 
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Effect of the protease on haematological 
values in mice: Albino mice fed with 
standard pellet diet and tap water ad libitum 
were kept I identical laboratory conditions 
for five days.  The animals were divided into 
four groups, each group containing ten mice. 
Protease solution prepared in distilled water 
was injected intraperitoncally and daily for 
15 days at the dose level of 136 mg/kg 
(low), 205 ,g/kg (moderate) and 410 mg/kg 
bodyweight (High) to the first, second and 
third group of mice respectively.  The fourth 
group received water (5.0 ml/kg) daily. 
Animals were sacrificed 24 hours after the 
last dose. Blood was collected from tailveins 
and by cardiac puncture with the help of 
syringe previously rinsed with heparin. 
 
Estimation of red blood cell count, white 
blood cell count, differential count of 
leucocytes, haemoglobin content of whole 
blood erythrocyte sedimentation rate (ESR) 
were carried out according to the normal 
procedure
8,9,10 for determination of these 
parameters.  For estimation of clotting time, 
blood from tail was allowed to fill capillary 
tube held horizontally. After few seconds, 
sections of the tube were broken off once 
every ten seconds till the appearance of fine 
fibrin threads at the broken end indicating 
clotting of the broken end indicating clotting 
of the blood.  The time required from 
appearance of the blood at the tail to the 
time of clotting measured by stop watch was 
the clotting time of the blood
8. 
 
Wound healing responses of the protease: 
 
Mice maintained on standard pellet diet with 
tap water ad libitum were acclimatized for a 
period of 15 days.  The hairs from the dorsal 
plane of thora columbar region of each 
animal was removed by shaving and 
rectangular wound of about 1.5 cm x 0.5 cm 
was produced surgically extending to the 
muscle to a depth of about 0.2 cm.  The 
animals were divided randomly into five 
groups (Groups 1 through 5) containing five 
mice in each group.  Animals of group 1 
were left as untreated control while the 
treatment of wounds of the mice of groups 
2,3,4 and 5 were started immediately by the 
application of ointment once a day as 
follows: 
 
Group 1:  Untreated control. 
Group 2:  Hydrophilic ointment base. 
Group 3:  Soframycin skin cream. 
Group  4:  Oinment containing the 
protease (0.5% w/w) in hydrophilic ointment 
base. 
Group  5:  Oinment Containing the 
protease (1.0%w/w) in hydrophilic ointment 
base. 
 
On 5
th day from the creation of wound, the 
tissue extending about 0.2 cm beyond the 
would area was collected from one mouse of 
each group. Similarly, the wound tissue 
from one mouse of each group was collected 
on 10
th, 15
th and 20
th day and were 
processed according to laboratory 
procedure.
11  The histopathological changes 
during the healing process were studied. 
 
Anti-inflammatory activity of the 
protease:  The anti-inflammatory activity of 
the protease sample was evaluated by 
carragenan induced rat hind paw ocdema 
method
12. The animals were acclimatized for 
a period of seven days maintaining on 
standard pellet diet and were kept in fasting 
condition overnight before starting the 
experiment.  The tats were divided into three 
groups taking five animals in each group. 
 
Protease solution, 25.0 mg/ml and 
carragenan solution, 1.0% (w/v) were 
prepared in normal saline. The animals of 
prepared in normal saline.  The animals of 
group I (Control) received saline (1.0 ml 
kg), group II (Standard) received diclofenac 
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sodium (25.0 mg/kg) and group III (Test) 
received protease sample (25.0 mg/kg) in 
right hind paw. After one hour of this 
treatment 0.1 ml of 1.0% carragenan 
solution was injected to the same paw of 
each animal of all the groups.  All the 
injections were given by sub plantar route of 
administration.  Observation in mercury 
plethysmometer were made immediately 
after carragenan injection (Zero hour) and 
repeated after every one hour for three 
hours.  The precent swelling of the paw of 
each animal at different times were 
calculated and the average paw swelling of 
the rats of groups II and III were compared 
with that of control rats (Group 1) and the 
percent inhibition of oedema formation was 
determined. 
 
RESULTS AND DISCUSSION 
 
The results of the haematological studies 
have been summarized in Table -1 and 
Table -2 and in Fig.1, Fig 2, Fig 3. An 
increase in the clotting time and erythrocyte 
sedimentation rate (ESR) were observed in 
all the three dose leaves.  The increase in 
clotting time was 15.4% with moderate dose 
and 16.4% with high dose.  In low dose, the 
increase was insignificant.  The increase in 
clotting time might because of proteolytic 
action of the enzyme sample on protein 
factors responsible for blood clotting. The 
increase in ESR was increased by 12.4%, 
53.9% and with the three dose level 
respectively.  This increase in ESR is 
possible due to decrease in the level of 
albumin or nucleoprotein 13 as a 
consequence of proteolytic action of the 
enzyme sample.  Haemoglobin content, 
RBC count and WBC count decreased in a 
dose dependent manner.  Haemoglobin 
content was decreased by 10.8%, 15.9% and 
26.4% respectively in low, moderate and 
high dose treated mice.  The RBC count was 
decreased by 7%, 10.3% and 13.9% 
respectively whereas WBC count was 
decreased by 6.9%,9.3% and 10.1% 
respectively for the three dose levels.  The 
decrease in RBC count might ;be due to loss 
of some stimulus that constantly act on the 
bone marrow in order to replace the lost 
cells, Haemoglobin content is related with 
red cell count and its decrease is because of 
decrease in the red cell count in protease 
treated animals.  The rise in neutrophil and 
fall in Iymphocyte count might be due to 
increased hydrolysis of nuclcoprotein 
because of protease action. Thus it clearly 
signifies that the protease affects 
haemopoietic system and greatly alters the 
level of haematolgical parameters in 
animals. 
 
The observations on wound healing 
responses of the protease are shown in 
tabular form in Table – 3.  The untreated 
control wounds and the wounds treated with 
washable ointment base showed delayed and 
incomplete healing even on the twentieth 
day while the wounds treated with 
soframycin skin cream and ointment 
containing 0.5% (w/W) protease showed a 
better healing quality than the first two 
groups and were found to be equally 
effective on wound healing.  The 1.0% 
(w/w) protease showed a better healing 
quality than the first two groups and were 
found to be equally effective on wound 
healing.  The 1.0% (W/W) protease 
ointment, on the other hand revealed a much 
faster healing with normal epithalialization 
and keratinization on 20
th day. 
Microphpotographs showing the wound 
healing response of the protease have been 
given in Fig, 4,5 and 6.  The use of 
proteolytic enzymes in the treatment of 
wound the been indicated earlier also.
14,15 
Nath and Dutta
16 have reported the wound 
healing property of curcain, a protease 
isolated form Jatropha curcas Linn.  The 
selective digestion of the dead tissue and 
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cells of the wound is achieved by the 
proteolytic enzymes which facilitate wound 
drainge decreasing the time needed for 
healing. 
 
The results of the study on anti 
inflammatory activity are presented I Table -
4. The percent swelling of the paw of rats 
after one, two and three hours of carrageen 
injection were calculated with respect to the 
observation at Zero time using the equation 
17 
 
Percent Swelling = V-Vi   x100 where, 
                                 Vi 
 
V is the plethysmometer reading at different 
times after the carrgenan injection and Vi is 
the initial reading at Zero time. The 
inhibition of oedema formation were 
determined using the equation 
17 
 
Percent inhibition =   Percent swelling of enzyme treated group  x100  
                                   Percent swelling of control group 
 
Percent inhibition of oedema formation by 
the protease was remarkably lower than that 
of the diclofenac sodium in all the 
observations of respective intervals.  The 
inhibition of oedema formation by the 
protease was found highest at one hour after 
carragenan injection with gradual decrease 
with time.  Several proteolytic enzyme 
preparations are used to reduce acute 
inflammations following surgery or atheletic 
injuty
18. Inhibition of swelling in carragenan 
induced inflammation by the protease might 
be due to disruption of one or more enzyme 
systems which are responsible for gensesis 
of inflammation. Of course, the anti-
inflammatory action was notably weaker 
than that of the established anti-
inflammatory drug. 
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TABLE 1: Effect of the protease form Ficus hispida on Haematological parameters in mice. 
(Values are mean ± SEM of 10 experiments in each case) 
Protease Solution    Parameters  Water 
5.0ml/kgb.w 
 
136 mg/kg 
b.w 
205mg/kg b.w  410 mg/kg b.w. 
Clotting time 
(sec) 
Haemoglobin 
content (%) 
ESR (mm/hr) 
RBC count (x 
1066/mm/hr) 
WBC count 
216.5 ± 4.54 
 
76.0 ± 1.09 
 
0.89 ± 0.03 
 
2.52 ± 0.02 
58.35 ± 65 
227.6 ± 4.05 
 
67.8 ± 0.84* 
 
1.0 ± 0.03* 
 
2.34 ± 0.01* 
5445 ± 53* 
249.9 ± 2.06* 
 
63.9 ± 0.82* 
 
1.37 ± 0.07* 
 
2.26 ± 0.01* 
5295 ± 47* 
252.0 ± 1.69* 
 
55.9 ±  0.82* 
 
1.42 ±  0.08* 
 
2.17 ±  0.01* 
5250 ±  53*  
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   The Statistical significance of difference between means were calculated by “Student’s test”. 
*p<0.05 
 
Table 2: Effect of protease from Ficus hispida on Differential leucocyte count in mice. 
(Values are mean-SEM of 10 experiments in each case) 
 
Protease Solution  Parameters Water  5.0ml/kgb.w 
 
136 mg/kg b.w  205mg/kg b.w  410 mg/kg b.w. 
Neutrophil 
 
Eosinophil 
 
Basophil 
 
Lymphocyte 
 
Monocyte 
18.0 ± 0.82 
 
8.9 ± 0.28 
 
1.6 ± 0.34 
 
55.1 ± 0.78 
 
16.4± 0.69 
20.9 ± 0.94* 
 
9.5 ± 0.37 
 
1.7 ± 0.26 
 
51.3 ± 1.04* 
 
16.6 ± 0.70 
34.9 ± 0.82* 
 
9.6 ± 0.43 
 
1.4 ± 0.31 
 
37.0 ± 0.92* 
 
17.1 ± 0.50 
42.1 ± 1.07* 
 
9.0 ± 0.39 
 
1.5 ± 0.31 
 
29.4-1.02* 
 
18.0-0.47 
    
The statistical signigicance of difference between means were calculated by “Student’s test “. 
*p<0.05 
 
Table 3: Results of the wound healing response of protease from Ficus hispida on mice 
 
Observation on day  Animal 
Group 
 
5 10  15  20 
1 Necrosis,  haemorrhage 
with RBC,LPC and 
PMNL 
LPC,PMNL,PC  Formation of GT and 
SET 
Matured GT, 
EPTL 
2 Necrosis,  haemorrhage 
with RBC,LPC and 
PMNL 
LPC,PMNL,PC  Formation of GT and 
SET,IFC 
IFC,EPTL, 
Beginning of 
KTN 
3  Necrosis, IFC (acute) 
PMNL 
IFC (Chronic), LPC 
PMNL, formation of GT 
Matured GT,EPTL  Normal  EPTL, 
KNT 
4  IFC (acute), PMNL  LPC,PMNL,  IFC 
(Chronic), Formation of 
GT 
Matured GT,EPTL  EPTL,  mild 
KTN 
5  IFC (acute), PMNL  Formation  of  GT,  IFC 
IFC (Chronic) 
Matured GT,EPTL  Normal  EPTL, 
Normal KTN 
   
RBC – Red blood cells, LPC- Lymphocytes,  PMNL – Polymorphonuclear leucocytes 
IFC – Inflammatory cells, PC – Plasma cells, GT- Granulation tissue 
SET – Subepithalial tissue,  EPTL – Epithalialization, KTN – Keratinization 
 
Table 4: Anti-inflammatory activity of protease fron ficus hispida on rats 
 
Group 
No. of 
 
Treatment (One 
Observation in mm-SEM of 5 
experoments after carragenan 
Percent swelling  Percent inhibition of 
oedema formation 
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injection  rats 
 
hour before 
carragenan 
injection) 
0hr  1hr 2hr 3hr  1hr  2hr  3hr  1hr 2hr  3hr 
I 
 
 
II 
 
 
 
III 
Control (Saline, 
1.0ml/kg) 
 
 
Diclofenac 
sodium 
(25.0mg/kg) 
 
 
Protease 
 
 
1.58 
± 
0.04 
 
1.62 
± 
0.04 
1.64 
± 
0.02 
2.0 ± 
0.05 
 
 
1.84 
± 
0.02 
 
1.94 
± 
0.02 
2.12 
± 
0.04 
 
 
1.94 
± 
0.02 
 
2.06 
± 
0.02 
2.46 ± 
0.02 
 
 
2.12 
± 
0.04 
 
2.36 
± 
0.02 
26.58 
 
 
 
13.58 
 
 
18.29 
34.18 
 
 
 
19.75 
 
 
25.61 
55.69 
 
 
 
30.86 
 
 
43.90 
- 
 
 
 
48.91 
 
 
31.19 
- 
 
 
 
42.22 
 
 
25.07 
- 
 
 
 
44.59 
 
 
21.17 
 
Legend of the Figures: 
 
Fig 1 Effect of protease from Ficus hispida on Haematological parameters in mice  
(A) Clotting time (See)  (B) Haemoglobin content (%) 
 - Water,    - Low dose,    - moderate dose,     - High dose 
 
 
Fig. 2 Effect of protease from Ficus hispida on Haematological parameters in mice  
(C) ESR (mm/hr)    (D) RBC Count (X106/mm3) 
 - Water,    - Low dose,    - moderate dose,     - High dose 
 
Fig. 3 Effect of protease from Ficus hispida on Haematological parameters in mice  
(E) WBC Count (mm3)    (F) Differential leucocyte count (%) 
 - Water,    - Low dose,    - moderate dose,     - High dose 
 
Fig 4 Histology of the wound tissue of mice treated for 10 days with ointment 
Containing 0.5% (w/w) protease from Ficus hispida (Magnification x 400) 
 
Fig 5 Histology of the wound tissue of mice treated for 10 days with ointment 
Containing 1.0% (w/w) protease from Ficus hispida (Magnification x 400) 
 
Fig 6 Histology of the wound tissue of mice treated for 20 days with ointment 
Containing 1.0%n (w/w) protease from Ficus hispida (Magnification x 400) 
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